Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of ovarian cancer ascites cells

ABSTRACT: mRNA from tumor cells, tumor associated macrophages and tumor associated T cells from high grade serous ovarian carcinoma patients was sequenced.

INSTRUMENT(S): Illumina HiSeq 1500

ORGANISM(S): Homo sapiens

SUBMITTER: Florian Finkernagel

PROVIDER: E-MTAB-5498 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

The transcriptional signature of ascites-associated macrophages is linked to interferon signaling and a favorable clinical outcome in a subgroup of ovarian carcinoma patients

Project description:mRNA from tumor associated macrophages from high grade serous ovarian carcinoma patients was sequenced.

2017-02-01 | E-MTAB-5199 | biostudies-arrayexpress

A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome

Project description:Transcriptome of high grade serous ovarian carcinoma isolated from patient acites and associated macrophages was analyzed using RNASeq.

2016-02-29 | E-MTAB-4162 | biostudies-arrayexpress

Mixed-polarization phenotype of ascites-associated macrophagesin human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse

Project description:Ascites-associated macrophages were collected from human ovarian carcinoma patients and their expression profiles determined via Agilent microarrays. In addition, monocyte derived macrophages from healthy donors were differentiated ex-vivo with MCSF and GMCSF and their expression profiles determined as well.

2014-03-07 | E-MTAB-1661 | biostudies-arrayexpress

Deregulation of PPAR-beta/delta target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment - RNAseq

Project description:The transcriptome of serous ovarian cancer tumor associated macrophages was characterized. Additionally, their transcription response to PPARD agonists and inverse agonists in cell culture was analyzed.

2015-05-31 | E-MTAB-3167 | biostudies-arrayexpress

The intercellular signaling network of ovarian cancer metastases

Project description:Primary cells from high grade serous ovarian carcinoma patients, derived from ascites and omentum were sequenced to study signaling networks.

2021-11-01 | E-MTAB-10611 | biostudies-arrayexpress

Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment - ChIPseq

Project description:PPARD and RXR genome wide binding in tumor associated macrophages from serous ovarian carcinoma was characterized.

2015-06-01 | E-MTAB-3166 | biostudies-arrayexpress

Cell-Type–Resolved Proteomics Reveals Distinct Immune and Metabolic Programs between Primary and Recurrent Ascites in High-Grade Serous Ovarian Cancer

Project description:This study presents a cell-type–resolved quantitative proteomics analysis of paired primary and recurrent ascites samples from patients with high-grade serous ovarian carcinoma (HGSOC). Ascites samples were collected from three patients (IROC60, IROC65, and IROC126) at diagnosis and upon disease recurrence following platinum–taxane chemotherapy. For each sample, ascites-derived cells were fractionated into unsorted, CD45⁻ (tumor-enriched), and CD45⁺ (immune-enriched) populations using magnetic-activated cell sorting. Using label-free LC–MS/MS proteomics, we quantified proteome-wide changes associated with disease recurrence across distinct cellular compartments. Pathway-level analyses revealed consistent suppression of interferon signaling across tumor and immune fractions, alongside enhanced oxidative phosphorylation and metabolic reprogramming in recurrent tumor cells. Immune-enriched fractions exhibited signatures of immunosuppression, including reduced antigen presentation and enrichment of regulatory and monocyte-related pathways. Together, this dataset provides a comprehensive proteomic resource for investigating tumor–immune interactions and recurrence-associated molecular remodeling within the ovarian cancer ascites microenvironment.

2026-08-18 | PXD073562 | Pride

Chemotherapy-polarized macrophages from human breast cancer

Project description:Chemotherapies have been shown to enhance anti-tumor immunity, but whether chemotherapies affect tumor-associated macrophages (TAMs) is still unclear. We found TAMs is different before and after chemotherapy by comparing proteomic profiles of TAMs before and after chemotherapy.

2021-02-16 | PXD022673 | Pride

Ovarian high grade serous carcinoma ascites cell secretome

Project description:The secretomes of tumor cells, and macrophages from high grade serous ovarian carcinoma from the ascites of patients undergoing primary surgery were analysed after 24h culture (ex vivo) via obitrap.

2017-11-17 | PXD008047 | Pride

Effect of prostacyclin in ovarian carcinoma

Project description:CAFs, ascTAMs and M1- and TAM-like-MDMs were treated with 1 μM of the Prostacyclin analoga MRE and DMSO (as solvent control). The aim of this experiment is to see which effect MRE (Prostacyclinanaloga) has on RNA expression (activation of signaling pathways). Background: Prostacyclin receptor expression is elevated in TAMs. Prostacyclinsynthase expression was detected mainly in CAFs. (

2022-12-16 | E-MTAB-12437 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data